IBM's October 21 Earnings Call Is the Only Catalyst That Matters Now
Published on 09/23/2026 at 12:50 | Editorial boerse-global.de
IBM investors have spent most of 2026 watching the company's research arm generate headlines while its core business generated disappointment. On October 21, that split-screen narrative gets its first real test, when the Armonk-based technology giant reports third-quarter results after the U.S. market close.
The setup is unusually binary. Shares recently changed hands at 203.10 EUR, up 0.4% on the day, but down 22% since the start of the year — a decline that has left the stock searching for a floor while management tries to convince the market that its turnaround is more than a slide deck.
The Number That Matters Most
Strip away the quantum computing announcements and the AI partnerships, and IBM's investment case still rests on one figure: currency-adjusted revenue growth. The company trimmed its full-year 2026 guidance to a range of 4% to 5%, down from an earlier target of more than 5%. That corridor is now the credibility test for CEO and management team alike.
Fall short of the lower bound in the third quarter, and the entire annual plan starts to wobble. Confirm the range, and the confidence deficit that has built up over the summer could begin to close. Consensus estimates, according to media reports, point to quarterly revenue of 16.82 billion USD and earnings per share of 2.88 USD.
Those projections land against a bruising second quarter, when IBM posted revenue of 17.16 billion USD against expectations of 17.86 billion USD. Adjusted earnings per share of 2.93 USD also missed the mark. The shortfall laid bare how little cushion the company has when its software and consulting engines sputter — no amount of promising research can plug a revenue hole in the near term.
Should investors sell immediately? Or is it worth buying IBM?
Where the Optimism Lives
The bull case rests on a research pipeline that has been unusually productive in recent months. On September 10, IBM and NASA unveiled the open-source "NASA–IBM Lunar Foundation Model," trained on imagery from four separate NASA missions and data from nine scientific instruments. The system outperforms conventional methods by up to 22% in identifying ice deposits and by 19% in crater detection — gains that matter for any long-term human presence on the Moon.
State backing has arrived as well. IBM's subsidiary Anderon finalized more than 1 billion USD in funding from the U.S. Department of Commerce under the CHIPS and Science Act, money earmarked for research and development in quantum wafer manufacturing. The company also signed a definitive agreement on July 23, 2026, to acquire HRL Laboratories, LLC, a research institute previously co-owned by Boeing and General Motors. Financial terms were not disclosed.
International partnerships round out the picture. IBM announced an innovation hub with Lockheed Martin at ETH Zurich that will house the company's first quantum computer in Switzerland. Separately, a research team from the Cleveland Clinic, Japan's RIKEN institute, and IBM reached the finals for the 2026 ACM Gordon Bell Prize for modeling a protein on quantum computers.
The Adoption Problem Nobody Talks About
Less visible, but potentially more consequential for near-term revenue, is a skills gap that IBM's own research arm has now quantified. A global study published Monday by the IBM Institute for Business Value found that 60% of employees worry AI is eroding critical thinking. While 71% of HR executives consider validating AI outputs an essential core competency, only 29% of workers place high importance on their own judgment.
That disconnect threatens to slow enterprise rollouts of complex software. When clients hesitate on implementation, the effect shows up with a lag — in softer consulting revenue and weaker software bookings. It is a structural headwind that no chip subsidy can offset.
Two Paths From Here
For shareholders, the calculus splits cleanly. Hold the 4% to 5% currency-adjusted growth range, and the quantum and foundation-model work will likely re-emerge as a share price driver rather than a footnote. Miss it, and the doubts about the pace of IBM's reinvention will only deepen.
The next hard data point is set. On October 21, 2026, IBM delivers its third-quarter numbers — and with them, the clearest evidence yet of whether the company's operational reality can keep pace with its technological ambition.
Ad
IBM Stock: New Analysis - 23 September
Fresh IBM information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
